Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.2035
https://www.valueinhealthjournal.com/article/S1098-3015(13)03947-8/fulltext
Title :
Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03947-8&doi=10.1016/j.jval.2013.08.2035
First page :
A686
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1861